Related Experiment Videos
Recombinant IL-2 given intra-splenically and intravenously in advanced malignant melanoma: a phase I/II study
1Christie Hospital & Paterson Institute of Cancer Research, Manchester, U.K.
Cancer Treatment Reviews
|June 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.
Cancer treatment reviews·2026
Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.
Cancer treatment reviews·2026
Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.
Cancer treatment reviews·2026